Viewing Study NCT01894451


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-06-14 @ 11:19 AM
Study NCT ID: NCT01894451
Status: COMPLETED
Last Update Posted: 2019-12-12
First Post: 2013-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Sponsor: Dana-Farber Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inflammatory Breast Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Inflammatory Breast Carcinoma View
None 89Zr-bevacizumab View